Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

4.45
Delayed Data
As of Jan 27
 -0.10 / -2.20%
Today’s Change
2.94
Today|||52-Week Range
20.48
-8.81%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gad Thomas
Director
Sale2/08/2022125,863$7.01$882.3K-35.84%
Gad Thomas
Director
Sale2/04/2022101,104$7.70$778.5K-42.34%
Gad Thomas
Director
Sale2/07/202291,031$7.59$690.9K-40.72%
Gad Thomas
Director
Sale2/09/202264,276$6.96$447.4K-36.84%
Gad Thomas
Director
Sale2/03/202235,060$7.90$277.0K-43.87%
Gad Thomas
Director
Sale2/01/20228,000$10.15$81.2K-55.60%
Kruse Bo
Sale2/04/20224,000$7.97$31.9K-42.34%
Kruse Bo
Sale2/22/20224,000$7.85$31.4K-43.73%
Gad Thomas
Director
Buy2/01/20228,000$2.00$16.0K-55.60%
Rajah Vignesh
Chief Medical Officer & Senior Vice President
Buy11/15/20221,195$4.92$5.9K-0.45%
Page of 2